Geron to Present at Upcoming Investor Conferences in November
- Stifel 2018 Healthcare Conference in
New Yorkat 2:00 p.m. ETon Wednesday, November 14, 2018
- 30th Annual
Piper Jaffray Healthcare Conferencein New Yorkat 11:30 a.m. ETon Tuesday, November 27, 2018
A live audio webcast of each presentation will be available on Geron’s website, www.geron.com/investors/events. If you are unable to listen to the live presentations, an archived webcast of each presentation will be available on the Company’s website for 30 days.
Geron is a clinical stage biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
Source: Geron Corporation